On October 6, 2021 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that members of the management team will be presenting virtually at the following H.C. Wainwright Investor Conferences (Press release, Altimmune, OCT 6, 2021, View Source [SID1234590969]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 5th Annual NASH Investor Conference
Tuesday, October 12, 2021
3:30 pm Eastern Time
H.C. Wainwright Hepatitis B Virus (HBV) Virtual Conference
Wednesday, October 13, 2021
4:30 pm Eastern Time
The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.